Spryte Medical Announces Positive Results from the INSYTE Pivotal Trial at SVIN 2026
The first FDA-approved pivotal trial of an intravascular optical imaging device in the neurovasculature met the primary effectiveness endpoint, showed favorable safety and prospectively documented changes in investigator clinical decision-making following nOCT imaging.